The past year has been a roller-coaster ride for domestic pharmaceutical companies, with many manufacturing facilities coming under the international regulatory scanner for alleged deviation from norms. A look at how these developments have affected operations at three drug facilities:
UNDER LENS
Indian drug makers that received US FDA import alerts in 2013
- Amsal Chem, Ankleshwar, Gujarat- 1 unit
- Global Calcium, Hosur, Tamil Nadu- 2 units
- Global Calcium, Bangalore- 3 units
- Kamud Drugs, Sangli, Maharashtra- 1 unit
- Konduskar Laboratories,Kagal, Maharashtra - 1 unit
- Micro Labs, Bangalore- 1 unit
- Promed Exports, Solan, Himachal Pradesh- 1 unit
- RPG Life Sciences, Ankleshwar, Gujarat- 1 unit
- RPG Life Sciences, Thane,Maharashtra- 1 unit
- Ranbaxy Laboratories, Mohali, Punjab- 2 units
- Smruthi Organics, Solapur, Maharashtra- 1 unit
- Unique Chemicals,Mumbai, Maharashtra- 1 unit
- Vignesh Life Sciences, Hyderabad, Andhra Pradesh- 1 unit
- Vignesh Life Sciences Bellary, Karnataka- 1 unit
- Wockhardt, Aurangabad, Maharashtra-1 unit
Source: US FDA website
